O-Xylene

O-Xylene

SCHEMBL27600417

Cc1ccccc1C.Clc1cncc(Cl)n1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.48
TSHR P16473 1/20 0.48
CDK2 P24941 2/20 0.47
CTSA P10619 1/20 0.41
ALDH1A1 P00352 4/20 0.39
GRM5 P41594 1/20 0.38
GPBAR1 Q8TDU6 1/20 0.36
CYP2A6 P11509 1/20 0.36
LMNA P02545 1/20 0.35
NQO2 P16083 1/20 0.34
LRRK2 Q5S007 1/20 0.34
HTR2A P28223 2/20 0.33
DRD2 P14416 1/20 0.33
HRH1 P35367 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5142203 0.80 IDO1 (0.44) CDK2CTSAALDH1A1GPBAR1LMNA
Iodobenzene SCHEMBL20985741 0.79 CDK2 (0.50) TSHRCDK2CTSAALDH1A1GRM5
SCHEMBL138054 0.79
SCHEMBL238833 0.72
SCHEMBL30899418 0.70
O-Xylene SCHEMBL27638879 0.70 TSHR (0.71) ACHETSHRALDH1A1CYP2A6LMNA
O-Xylene SCHEMBL6933035 0.69 TSHR (0.83) ACHETSHRALDH1A1CYP2A6LMNA
O-Xylene SCHEMBL170581 0.69 TSHR (1.00) ACHETSHRALDH1A1CYP2A6LMNA
O-Xylene SCHEMBL10522915 0.69 TSHR (1.00) ACHETSHRALDH1A1CYP2A6LMNA
O-Xylene SCHEMBL11034038 0.69 TSHR (1.00) ACHETSHRALDH1A1CYP2A6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100558715-C Kinases inhibitor CYTOPIA PTY LTD (AU) 2009-11-11 CN disclosed
CN-1656082-A Protein kinase inhibitors CYTOPIA PTY LTD (AU) 2005-08-17 CN disclosed